Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Kythera Biopharmaceuticals
company
About
Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $30M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Aug 1, 2005
- Number Of Employee
- 101 - 250
- Operating Status
- Active
KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California.
KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$98.40M
Kythera Biopharmaceuticals has raised a total of
$98.40M
in funding over 2 rounds. Their latest funding was raised on
Sep 19, 2011 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 19, 2011 | Series D | $37.40M | 3 |
Foley Ventures
|
— | Detail |
| May 19, 2008 | Series C | $30M | 4 |
|
— | Detail |
| Jul 24, 2006 | Series B | $30M | 2 | — | — | Detail |
| Sep 16, 2005 | Seed | $1M | 1 |
Versant Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
5
Kythera Biopharmaceuticals is funded by 5 investors.
Foley Ventures
and Jafco Life Science
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Foley Ventures
|
Yes | Series D |
|
|
Yes | Series C |
ARCH Venture Partners
|
— | Series D |
|
Versant Ventures
|
— | Series D |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
